The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $31.08

Today's change+0.40 +1.30%
Updated August 16 9:43 AM EDT. Delayed by at least 15 minutes.
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $31.08

Today's change+0.40 +1.30%
Updated August 16 9:43 AM EDT. Delayed by at least 15 minutes.

Omega Healthcare Investors Inc up (U.S.)$0.40

Omega Healthcare Investors Inc is up today by (U.S.)$0.40 or 1.30% to (U.S.)$31.08. Over the last five days, shares have gained 1.60%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 28.90% during the last year.

Key company metrics

  • Open(U.S.) $30.71
  • Previous close(U.S.) $30.68
  • High(U.S.) $31.10
  • Low(U.S.) $30.71
  • Bid / Ask(U.S.) $31.06 / (U.S.) $31.08
  • YTD % change-0.58%
  • Volume135,456
  • Average volume (10-day)1,864,506
  • Average volume (1-month)1,950,670
  • Average volume (3-month)2,255,698
  • 52-week range(U.S.) $28.11 to (U.S.) $38.09
  • Beta0.54
  • Trailing P/E17.00×
  • P/E 1 year forward17.38×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.56
  • Dividend yield8.24%
  • Trailing EPS(U.S.) $1.83
Updated August 16 9:43 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+41.83%

Based on its net profit margin of 41.83%, Omega Healthcare Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.27%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue236232234225
Total other revenue--------
Total revenue236232234225
Gross profit--------
Total cost of revenue--------
Total operating expense959388100
Selling / general / administrative14151712
Research & development--------
Depreciation / amortization70707168
Interest expense (income), net operating--------
Unusual expense (income)108020
Other operating expenses, total--------
Operating income141139147124
Interest income (expense), net non-operating-51-48-47-45
Gain (loss) on sale of assets-17305
Other--------
Income before tax6811013082
Income after tax6810812982
Income tax, total1110
Net income6510412479
Total adjustments to net income--------
Net income before extra. items6510412479
Minority interest-3-5-6-4
Equity in affiliates110--
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6510412479
Inc. avail. to common incl. extra. items6510412479
Diluted net income6810412479
Dilution adjustment3------
Diluted weighted average shares207206205204
Diluted EPS excluding extraordinary itemsvalue per share0.330.510.610.38
Dividends per sharevalue per share0.620.610.600.58
Diluted normalized EPSvalue per share0.380.510.460.46